DOCS
Doximity, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth -5.9% ·
share flow +13.9% ·
net new positions -6.2%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | -8 | 101.96M | $2.11B | +7 | −14 |
| Q1 2026 | 124 | -12 | 93.12M | $2.18B | +2 | −15 |
| Q4 2025 | 137 | +3 | 98.50M | $4.36B | +5 | −1 |
| Q3 2025 | 20 | -1 | 62.52M | $4.57B | — | −2 |
| Q2 2025 | 19 | 0 | 60.43M | $3.71B | +1 | −1 |
| Q1 2025 | 16 | -1 | 22.41M | $1.30B | +1 | −2 |
| Q4 2024 | 17 | +2 | 19.67M | $1.05B | +2 | — |
| Q3 2024 | 14 | +1 | 14.27M | $621.81M | +2 | −1 |
| Q2 2024 | 13 | — | 13.99M | $391.40M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 4.12M | -16.6% | $239.27M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 4.12M | -16.6% | $239.27M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 4.12M | -16.6% | $239.27M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 4.12M | -16.6% | $239.27M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 4.05M | +4.1% | $234.86M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 3.38M | +14.4% | $196.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 3.38M | +14.4% | $196.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 3.06M | +65.7% | $177.62M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 1.60M | +6.1% | $92.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 1.51M | +55.7% | $87.85M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.51M | +55.7% | $87.85M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | Capital World Investors ✦ | 1.39M | -19.2% | $80.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 1.18M | +31.8% | $68.56M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 646.45K | +14568.8% | $37.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 646.45K | +14568.8% | $37.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 504.60K | +19.3% | $28.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 504.60K | +19.3% | $28.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 504.60K | +19.3% | $28.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 504.60K | +19.3% | $28.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 504.60K | +19.3% | $28.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Norges Bank ✦ (passive) | 379.65K | +364.1% | $22.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Millennium Management ✦ | 268.37K | +90.7% | $15.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 126.22K | -30.2% | $7.33M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 126.22K | -30.2% | $7.33M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 114.84K | New | $6.66M | 0.0% | New | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 61.73K | +28.6% | $3.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Wellington Management ✦ | 11.64K | +74.9% | $675,411 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $6.66M | 0.0% |
Exited
| Marshall Wace | $3.14M | was 0.0% |
| Bridgewater Associates | $225,413 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 418 holders, 119.59M shares, $2.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.77K sh · $44,144
Director · 7.50K sh · $293,325
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology